TRANSLATE BIO, INC.

TBIO NASDAQ
9.72
-0.01
-0.10%
已收盘, 17:53 07/17 EDT
开盘
9.74
昨收
9.73
最高
9.84
最低
9.50
成交量
5.20万
成交均量(3M)
21.01万
52周最高
16.60
52周最低
4.810
换手率
0.12%
市值
4.19亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供TRANSLATE BIO, INC. TBIO股票价格,TRANSLATE BIO, INC.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Translate Bio, Inc. is a messenger RNA, or mRNA, therapeutics company. The Company is developing medicines to treat diseases caused by protein or gene dysfunction. The Company is using its proprietary mRNA therapeutic platform, or MRT platform, and it create mRNA that encodes functional proteins. The mRNA is delivered to the target cell where the cell’s own machinery recognizes it and translates it, restoring or augmenting protein function to treat or prevent disease. The MRT product candidate for the lung, MRT5005, is designed to address the underlying cause of CF by delivering mRNA encoding fully functional CFTR protein to the lung epithelial cells through nebulization.
展开 >

最近浏览

名称
价格
涨跌幅